Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome

Abstract Background Cutaneous squamous cell carcinoma (cSCC) is not uncommon in association with indolent malignancies that were treated with prior radiotherapy and after allogenic bone marrow transplantation. On the other hand, cutaneous T-cell lymphoma (CTCL) is a subtype of non-Hodgkin’s lymphoma...

Full description

Bibliographic Details
Main Authors: Karam Khaddour, Amy Musiek, Lynn A. Cornelius, Farrokh Dehdashti, Peter Westervelt, Ryan Fields, George Ansstas
Format: Article
Language:English
Published: BMJ Publishing Group 2019-12-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Cutaneous squamous cell carcinoma
Cutaneous T-cell lymphoma
Sézary syndrome
Immune checkpoint inhibitors
Allogenic hematopoietic cell transplant
Pembrolizumab
Online Access:http://link.springer.com/article/10.1186/s40425-019-0801-z

Internet

http://link.springer.com/article/10.1186/s40425-019-0801-z

Similar Items